v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Net sales $ 1,202,876 $ 91,942 $ 1,723,936 $ 176,242
Cost of sales 14,796,130 1,511,360 21,021,429 3,259,335
Gross loss (13,593,254) (1,419,418) (19,297,493) (3,083,093)
Operating expenses        
Selling, general and administrative 7,005,537 3,949,081 13,891,367 9,514,868
Research and development 2,123,860 1,616,604 5,987,575 3,518,840
Total operating expenses 9,129,397 5,565,685 19,878,942 13,033,708
Other (loss) income (11,699,666) 0 (148,305,618) 864,900
Loss from operations (34,422,317) (6,985,103) (187,482,053) (15,251,901)
Interest expense (income), net 10,478,717 124,346,806 (4,441,756) 111,323,317
Loss before benefit for income taxes (44,901,034) (131,331,909) (183,040,297) (126,575,218)
Benefit for income taxes (1,281,947) 0 (18,914,439) 0
Net loss $ (43,619,087) $ (131,331,909) $ (164,125,858) $ (126,575,218)
Net loss per share of common stock - basic (in usd per share) $ (0.35) $ (1.76) $ (1.33) $ (1.77)
Net loss per share of common stock - diluted (in usd per share) $ (0.35) $ (1.76) $ (1.33) $ (1.77)
Weighted average number of common shares outstanding - basic (in shares) 123,414,045 74,701,343 122,984,218 71,583,551
Weighted average number of common shares outstanding - diluted (in shares) 123,414,045 74,701,343 122,984,218 71,583,551

Source